UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
_________________
Date of Report (Date of earliest event reported): On January 11, 2016
InspireMD, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
001-35731 |
26-2123838 | ||
(State
or other jurisdiction of incorporation) |
(Commission File Number) | (IRS
Employer Identification No.) | ||
321 Columbus Avenue Boston, Massachusetts |
02116 | |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (857) 453-6553
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On January 11, 2016, Eli Bar gave notice that he will resign from his positions as senior vice president of research and development and chief technical officer of InspireMD Ltd., a wholly-owned subsidiary of InspireMD, Inc., effective March 11, 2016.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
InspireMD, Inc. | ||
Date: January 15, 2016 | By: | /s/ Craig Shore |
Name: Craig Shore | ||
Title: Chief Financial Officer |